Vávrová et al. showed altered erythrocyte activities of antioxidant enzymes in patients with metabolic syndrome (MetS) with central obesity who had higher activities of SOD and GR than in healthy subjects, though the activity of GPX1 was not significantly changed [15]. This evidence concerns the gene GPX1 and metabolic syndrome.